Stay updated on TAK-659 in AML Clinical Trial
Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.

Latest updates to the TAK-659 in AML Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision/version number has been updated from v3.5.2 to v3.5.3, indicating a minor site update without change to the underlying study details.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded 'Acute myeloid leukemia' as a topic tag and included a new Resources link to the Genetic and Rare Diseases Information Center for AML information.SummaryDifference0.1%

- Check38 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0. No changes to the trial content or page functionality are introduced.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study locations list was updated, with new sites added and some existing sites removed. This alters where potential participants can enroll in the trial.SummaryDifference0.0%

Stay in the know with updates to TAK-659 in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.